The main objective of the CERAD project is to improve and expand the research infrastructure located at the National Centre for Nuclear Research (NCBJ), utilized in research programs oriented at design and pre-clinical evaluation of new drugs carrying the radioactive probe (radio pharmaceuticals) and other multimodality probes, suitable for diagnostic or therapeutic application, with the particular focus on the biologically active carrier
molecules which can be traced at the cellular and molecular level
Carbon nanotube (CNT), a material with exceptional aspect ratio and great mechanical flexibility, has shown great promises as an active carrier
transport material in making high-speed flexible field-effect transistors (FETs).
In contrast, ECV profiling directly measures the electrically active carrier
concentration, which has direct influence on key performance parameters such as forward voltage and contact resistance.
Both demonstrations include broad industry support and active carrier
participation, with test scenarios driven by carrier requirements.
The preparation is based on hormones, combining DIK-60 hormone that "renovates" the cells with a unique active carrier
that delivers the hormone to the specific targets in the skin.
They provide true synchronous demodulation with active carrier
regeneration, very linear demodulation, good intermodulation figures, reduced harmonics and excellent pulse response.